Skip to main content
E

Epi Biotech Co., Ltd. — Investor Relations & Filings

Ticker · 446440 ISIN · KR7446440000 KO Professional, scientific and technical activities
Open in API
Filings indexed 62 across all filing types
Latest filing 2026-03-31 Declaration of Voting R…
Country KR South Korea
Listing KO 446440

About Epi Biotech Co., Ltd.

https://epibiotech.com/en/

Epi Biotech Co., Ltd. is a biopharmaceutical company focused on the research and development of treatments for hair loss. The company utilizes a large genomic database and AI-driven drug discovery platforms to advance its pipeline, which includes cell and antibody therapeutics for hair restoration. In addition to its primary focus, Epi Biotech conducts R&D in skin regeneration. The company also provides specialized preclinical Contract Research Organization (CRO) services, offering expertise in hair loss research and efficacy evaluation.

Recent filings

Filing Released Lang Actions
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is titled “정기주주총회 결과” (Regular Shareholders’ Meeting Results) and provides detailed voting outcomes for each agenda item (approval of financial statements, director appointments, amendment to articles of incorporation, stock option grants, etc.), along with voting percentages and attendance data. This is clearly an announcement of shareholder vote results from an annual general meeting, matching the definition of “Declaration of Voting Results & Voting Rights Announcements (DVA).”
2026-03-31 Korean
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Board/Management Information Classification · 1% confidence The document is a regulatory notification titled “사외이사의 선임ㆍ해임 또는 중도퇴임에 관한 신고,” detailing the appointment and removal of outside directors (사외이사) for Epibiotech. It is a disclosure of board composition changes, matching the definition of Board/Management Information (Code: MANG).
2026-03-31 Korean
주식매수선택권부여에관한신고
Transaction in Own Shares Classification · 1% confidence The document is a ‘주식매수선택권 부여 신고’ filed with the Financial Services Commission/KRX, detailing the company’s grant of stock options (a form of equity issuance to directors and employees). In our taxonomy, this corresponds to a transaction in the company’s own shares (issuance of equity or equity-linked instruments). Therefore, the best-fit category is POS (Transaction in Own Shares).
2026-03-31 Korean
사업보고서 (2025.12)
Annual Report Classification · 1% confidence The document is a 'Business Report' (사업보고서) for the 11th fiscal year (2025) of Epi Biotech Co., Ltd. It contains detailed company information, history, capital changes, governance, and business descriptions. In the Korean regulatory context, the '사업보고서' (Business Report) is the equivalent of the annual comprehensive report filed with the Financial Supervisory Service (FSS) and the Korea Exchange, which corresponds to the 10-K filing type in the provided schema. FY 11
2026-03-23 Korean
감사보고서제출
Audit Report / Information Classification · 1% confidence The document is a standalone 감사보고서 (audit report) containing the auditor’s opinion, key financial statement figures for the current and prior fiscal years, the name of the audit firm (삼일회계법인), the audit report reception date, and applied accounting standards. It is not the full Annual Report (10-K) nor merely an announcement; it is the actual audit report itself. Therefore, it matches the definition of an Audit Report / Information (AR). FY 2025
2026-03-23 Korean
주주총회소집공고
Proxy Solicitation & Information Statement Classification · 1% confidence The document is a 'Notice of General Meeting of Shareholders' (주주총회소집공고) for EpiBiotech. It contains the agenda for the meeting, including financial statement approval, director appointments, and remuneration limits, along with detailed financial statements (balance sheet, income statement, etc.) as reference materials for shareholders. This type of document is standard for proxy solicitation and shareholder information in preparation for an Annual General Meeting, fitting the definition of a Proxy Solicitation & Information Statement.
2026-03-13 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.